Keywords: neurex, plans, nda, filing, ziconotide, corp, says

Neurex Plans NDA Filing For Ziconotide

Article | 21 January 1998

Print This

Neurex Corp says that it has completed an interim analysis of data frompatients enrolled in a Phase III neuropathic pain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in